Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded related topics: Obstructive Sleep Apnea and MedlinePlus Genetics as metadata; to avoid alerts for minor changes, set an alert condition.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a site revision label 'Revision: v3.4.2' and removed a government funding notice along with unrelated related-topic links (e.g., Obstructive Sleep Apnea, MedlinePlus Genetics) and a prior revision label; there are no changes to core study content, eligibility, outcomes, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check27 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check34 days agoChange DetectedThe page now shows a glossary and updates UI labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA new Publications entry for Tirzepatide on obstructive sleep apnea-related cardiometabolic risk published in Nature Medicine (SURMOUNT-OSA) has been added.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a metadata version change with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.